Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03667378 · ClinicalTrials.gov registry record
Investigating the Impact of Proactive Palliative Care
A clinical trial of Metastatic Solid Tumor Cancers and Locally Advanced Solid Tumor Cancers, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- 83
- Enrollment target
- 1
- Study location
NCT03667378: Active study of Metastatic Solid Tumor Cancers and Locally Advanced Solid Tumor Cancers, sponsored by Memorial Sloan Kettering Cancer Center.
NCT03667378 is a study of Metastatic Solid Tumor Cancers and Locally Advanced Solid Tumor Cancers that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 83 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03667378, a study of Metastatic Solid Tumor Cancers and Locally Advanced Solid Tumor Cancers, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 83 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will test whether adding personalized supportive care to medical treatment on a clinical trial affects the study participants' ability and desire to discuss their symptoms, their concerns about the future, and their approach to coping with cancer. The effects of supportive care on participants' responses to questions about these topics will be compared with those of other study participants who are being treated for cancer in a clinical trial, but are not receiving personalized supportive care.
Primary Outcome
using the CanCORS Expectations Survey, which will assess, on a 4-point Likert-type scale, patients' expectations for therapeutic benefit after talking with their doctors about their experimental drug
Conditions Studied
Interventions
- BEHAVIORAL NCCN Distress Thermometer
- BEHAVIORAL Expectations Survey (CanCORS)
- BEHAVIORAL Values Survey (Serious Illness Care Program)
- BEHAVIORAL Functional Assessment of Cancer Therapy-General (FACT-G)
- BEHAVIORAL Hospital Anxiety and Depression Scale (HADS)
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2018-09-07 |
| Est. Completion | 2026-09 |
What the registry record for NCT03667378 still lists
NCT03667378 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 83 participants, a relatively small participant target.
The record links to 2 conditions, with Metastatic Solid Tumor Cancers appearing as the primary indexed condition, and to 5 interventions - of which NCCN Distress Thermometer is the first listed.
NCT03667378 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03667378 about?
NCT03667378 is a clinical study titled "Investigating the Impact of Proactive Palliative Care". This study will test whether adding personalized supportive care to medical treatment on a clinical trial affects the study participants' ability and desire to discuss their symptoms, their concerns about the future, and their approach to coping with cancer. The effects of supportive care on partici...
What is the current status of trial NCT03667378?
This trial is currently active not recruiting. The enrollment target is 83 participants. The study started on 2018-09-07. Estimated completion is 2026-09.
What conditions does trial NCT03667378 study?
This clinical trial studies the following conditions: Metastatic Solid Tumor Cancers, Locally Advanced Solid Tumor Cancers.
What interventions are being tested in trial NCT03667378?
The interventions under investigation include: NCCN Distress Thermometer (BEHAVIORAL), Expectations Survey (CanCORS) (BEHAVIORAL), Values Survey (Serious Illness Care Program) (BEHAVIORAL), Functional Assessment of Cancer Therapy-General (FACT-G) (BEHAVIORAL), Hospital Anxiety and Depression Scale (HADS) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03667378?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03667378 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02974647 · 83 participants · Phase 2
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
- NCT03919292 · 83 participants · Phase 1
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca
- NCT04626674 · 83 participants · Phase 1
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)
- NCT05277168 · 83 participants · Phase 1
A Trial TO Evaluate THE Safety, Tolerability, Pharmacokinetics, AND Efficacy OF Shr-a1904 IN Subjects With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI